TITLE:
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

CONDITION:
HIV Infections

INTERVENTION:
Indinavir sulfate

SUMMARY:

      To evaluate the tolerance, and comparative virologic and immunologic effects of the two
      combination regimens.
    

DETAILED DESCRIPTION:

      100 patients will be randomized to receive Zerit (Stavudine) + Epivir (Lamivudine) +
      Crixivan (Indinavir) and 100 patients will be randomized to receive Retrovir (Zidovudine) +
      Epivir (Lamivudine) + Crixivan (Indinavir).

      Patients will be treated for 48 weeks.
    

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  Documented HIV infection.

          -  CD4 cell count of 200 - 700 cells/mm3.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following symptoms or conditions are excluded:

        AIDS defining condition within 1 month of study entry.

        Prior Medication:

        Excluded:

        Patients with any history of antiretroviral therapy treatment.
      
